Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Not Yet Recruiting

A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy

NCT07609719

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
Locations
  • Alabama Neurology Associates Birmingham, Alabama, United States
  • Clinical Endpoints Scottsdale, Arizona, United States
  • Advanced Neurology of Colorado Fort Collins, Colorado, United States
  • Neurology Associates - Maitland Orlando, Florida, United States
View Trial Details
Not Yet Recruiting

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

NCT07557420

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +11 more
Locations
  • Research Site Chengdu, China
  • Research Site Dongguan, China
  • Research Site Shanghai, China
  • Research Site Wenzhou, China
View Trial Details

Related conditions